[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590896":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":27,"collaborators":29,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":35,"sex":41,"minAge":42,"maxAge":11,"enrollmentInfo":43,"targetDuration":11,"studyType":46,"phases":47,"briefSummary":49,"conditions":50,"keywords":11,"overallStatus":53,"whyStopped":11,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":11},{"fullName":5,"class":6},"Beijing Chao Yang Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Comprehensive Pulmonary Rehabilitation Program","EXPERIMENTAL",null,[13],"Behavioral: Comprehensive Pulmonary Rehabilitation Program",{"label":15,"type":16,"description":11,"interventionNames":17},"Standard Pulmonary Rehabilitation","ACTIVE_COMPARATOR",[18],"Behavioral: Standard Pulmonary Rehabilitation",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"BEHAVIORAL","Combined Aerobic + Resistance Training Program Mode: Cycle ergometry (stationary bicycle) Frequency: 3-5 sessions per week Program Duration: 12 weeks\n\nSession Structure:\n\n* 5-minute warm-up\n* Continuous or interval training (15-30 minutes)\n* 5-minute cool-downesistance Exercise Component\n\nMode: Dumbbell exercises + cycle ergometry\n\nFrequency: 3 sessions per week\n\nProgram Duration: 12 weeks\n\nSession Structure:\n\n* 5-minute warm-up\n* Training session (10-20 minutes)\n* 5-minute cool-down",[9],{"type":21,"name":15,"description":25,"armGroupLabels":26,"otherNames":11},"xercise Components:\n\nAerobic Exercise\n\nMode: Walking or jogging\n\nResistance Exercise\n\nMode: Elastic bands or dumbbells\n\nTraining Parameters:\n\nSession Duration: ≥35 minutes (combined aerobic + resistance)\n\nFrequency: 3-5 sessions per week\n\nProgram Duration: 12 weeks",[15],{"type":28,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[30],{"name":31,"class":32},"Beijing Municipal Health Commission","OTHER_GOV","100590896","effects-of-pulmonary-rehabilitation-on-quality-of-life-and-health-in-pulmonary-arterial-hypertension-patients-100590896",false,"NCT06973382","Effects of Pulmonary Rehabilitation on Quality of Life and Health in Pulmonary Arterial Hypertension Patients","Intervention Study of a Comprehensive Pulmonary Rehabilitation Program on Quality of Life and Prognosis in Patients With Pulmonary Arterial Hypertension","EPRQoL-PAH","Inclusion Criteria:Confirmed PH Diagnosis:\n\nRight heart catheterization-confirmed pulmonary hypertension\n\nMeets 2022 ESC\u002FERS Guidelines diagnostic criteria for:\n\n* Group 1 (PAH) or\n* Group 4 (CTEPH\u002Fother pulmonary artery obstructions)\n\nStabilized Treatment Status:\n\nGroup 1 (PAH): Received ≥3 months of targeted drug therapy\n\nGroup 4 (CTEPH): Completed ≥6 sessions of BPA\\* or reached therapeutic endpoint\n\nFunctional Capacity:\n\nWHO Functional Class I-III\n\nAge: ≥18 years\n\nConsent: Willing to provide written informed consent -\n\nExclusion Criteria:Physical Limitations:\n\nUnable to perform pulmonary rehabilitation exercises due to disability or congenital malformations\n\nCardiopulmonary Testing Contraindications:\n\nMedically unfit to complete CPET (cardiopulmonary exercise testing) after evaluation\n\nPoor Compliance:\n\nHistory of non-adherence making protocol completion unlikely\n\nLife Expectancy:\n\nPrognosis ≤1 year\n\n\\-","ALL","18 Years",{"count":44,"type":45},84,"ESTIMATED","INTERVENTIONAL",[48],"NA","Pulmonary hypertension (PH) is a major global health concern, affecting approximately 1% of the world's population. With global aging and increased life expectancy, its incidence continues to rise. PH is a progressive and disabling disease, with studies showing its progression correlates with worsening symptoms and increased mortality. Even with targeted medications, the prognosis remains poor across PH subtypes, with PAH patients showing only a 49% 7-year survival rate. The 2022 ESC\u002FERS guidelines emphasize that PH management requires a comprehensive, multidisciplinary approach. Beyond pharmacological and surgical treatments, rehabilitation has demonstrated benefits in improving exercise capacity, quality of life, functional class, and peak oxygen consumption. However, research on specific and effective comprehensive pulmonary rehabilitation programs remains lacking.",[51,52],"PAH","CTEPH","NOT_YET_RECRUITING","2025-05-14",{"date":56,"type":57},"2025-05-15","ACTUAL",{"date":59,"type":45},"2025-05-20",{"date":61,"type":45},"2027-10-31",{"name":5,"class":6}]